At A Glance
- 5-Amino-1MQ is a small molecule studied for blocking an enzyme called NNMT. It appears in metabolic research because that enzyme sits at a junction connecting nicotinamide, methyl groups, and energy-related processes.
- Early studies reported changes in fat-related and metabolic measures.
- Nicotinamide handling, methyl donors, and NAD-related pathways can overlap.
What Is 5-AMINO-1MQ?
5-Amino-1MQ is a small molecule studied for blocking an enzyme called NNMT. It appears in metabolic research because that enzyme sits at a junction connecting nicotinamide, methyl groups, and energy-related processes.
NNMT changes nicotinamide into another molecule while using a methyl donor. Blocking that step can affect several connected pathways. This is an enzyme-focused approach, rather than an appetite-hormone signal.
Why Does It Come Up In Body-Composition Research?
Early fat-cell and mouse work reported changes in adiposity and metabolic measures. Those studies made NNMT interesting as a research target and raised questions about which connected pathway explains the response.
Is 5-Amino-1MQ A Peptide Or A GLP-1 Compound?
Neither. It is a small-molecule enzyme inhibitor. GLP-1 compounds act at a hormone receptor, while 5-Amino-1MQ explores an internal metabolic step. Keeping that distinction in mind makes comparisons much more meaningful.
A Closer Look At 5-AMINO-1MQ
Here are the key observations and the context that helps explain them. The original sources are linked below if you would like to explore further.
| Study or context | What was explored | What it tells us | Useful context |
|---|---|---|---|
| Cell and mouse work | NNMT inhibition | Early studies reported changes in fat-related and metabolic measures. | These findings establish a preclinical research direction. |
| Mechanism | A connected metabolic junction | Nicotinamide handling, methyl donors, and NAD-related pathways can overlap. | A single weight measurement cannot identify which pathway explains a response. |
Common Questions About 5-AMINO-1MQ
What is 5-AMINO-1MQ?+
5-Amino-1MQ is a small molecule studied for blocking an enzyme called NNMT. It appears in metabolic research because that enzyme sits at a junction connecting nicotinamide, methyl groups, and energy-related processes.
Why does it come up in body-composition research?+
Early fat-cell and mouse work reported changes in adiposity and metabolic measures. Those studies made NNMT interesting as a research target and raised questions about which connected pathway explains the response.
Is 5-Amino-1MQ a peptide or a GLP-1 compound?+
Neither. It is a small-molecule enzyme inhibitor. GLP-1 compounds act at a hormone receptor, while 5-Amino-1MQ explores an internal metabolic step. Keeping that distinction in mind makes comparisons much more meaningful.
Sources
Want to go a little deeper? These links take you to the studies and official records behind the guide. Study registries describe the plan; published papers report the findings.
- Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in miceBiochemical Pharmacology · 2018
Primary mouse and cellular work. No human weight-loss conclusion can be drawn from this design.
- Think twice before injecting peptides bought online: unauthorized products can seriously harm youHealth Canada · 2026
For 5-AMINO-1MQ context, this official Canadian advisory explains why a research-use label does not establish authorization, safety, efficacy, or product quality for human use.
Explore 5-AMINO-1MQ
Review available strengths, pricing, stock status, and product documentation.